0001209191-17-023889.txt : 20170331
0001209191-17-023889.hdr.sgml : 20170331
20170331165409
ACCESSION NUMBER: 0001209191-17-023889
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170329
FILED AS OF DATE: 20170331
DATE AS OF CHANGE: 20170331
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0924
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YEAMAN KEVIN J
CENTRAL INDEX KEY: 0001200469
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 17731062
MAIL ADDRESS:
STREET 1: C/O DOLBY LABORATORIES, INC.
STREET 2: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-29
0
0001308547
Dolby Laboratories, Inc.
DLB
0001200469
YEAMAN KEVIN J
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
1
1
0
0
President and CEO
Class A Common Stock
2017-03-29
4
S
0
10000
52.5057
D
107895
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Class A Common Stock
118251
D
This transaction was executed in multiple trades at prices ranging from $52.50 to $52.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Shares held following the reported transactions include 118,251 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
/s/ Daniel Rodriguez, Attorney-in-Fact for Kevin Yeaman
2017-03-31